A study of influenza and influenza-related complications among children in a large US health insurance plan database

PharmacoEconomics

Volumn 21, Issue 4, 2003, Pages 273-283

  Loughlin, Jeanne ^a   Poulios, Nick ^b   Napalkov, Pavel ^c   Wegmüller, Yann ^c   Monto, Arnold S ^d  

^a Ingenix Inc   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; ANTITUSSIVE AGENT; RIMANTADINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASTHMA; BRAIN DISEASE; BRONCHITIS; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA BASE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH INSURANCE; HUMAN; INFANT; INFECTION CONTROL; INFLUENZA; MAJOR CLINICAL STUDY; NEWBORN; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SINUSITIS; UNITED STATES;

ACUTE DISEASE; ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DIRECT SERVICE COSTS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; INSURANCE, HEALTH; RETROSPECTIVE STUDIES; RISK FACTORS; SINUSITIS; UNITED STATES;

EID: 0037228708     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321040-00005     Document Type: Article

References (29)

1. Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Meal 1997; 39: 408-14
2. Sullivan KM. Health impact of influenza in the United States. Pharmacoeconomics 1996; 9 Suppl. 3: 26-33
3. Sullivan KM, Monto AS, Longini IM. Estimates of the US health impact of influenza. Am J Public Health 1993; 155: 1119-26
4. Kavet JA. Perspectives on the significance of pandemic influenza. Am J Epidemiol 1997; 127: 353-64
5. Couch RB. Advances in influenza virus vaccine research. Ann N Y Acad Sci 1993; 685: 803-12
6. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the USA, 1970-1978. Am J Public Health 1986; 76: 761-5
7. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 1999; 5: 659-71
8. Monto AS, Sullivan KM Acute respiratory illness in the community: frequency of illness and the agents involved. Epidemiol Infect 1993; 110: 145-60
9. Centers for Disease Control. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999; 48 (RR-4): 1-28
10. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rate of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-9
11. National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1994. Vital and health statistics. Series 10, no. 193. DHHS publication no. PHS 96-1521. Washington (DC): Government Printing Office, 1995
12. Perrotta DM, Decker M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 1985; 122: 468-76
13. Longini Jr IM, Koopman JS, Monto AS, et al. Estimating households and community transmission parameters for influenza. Am J Epidemiol 1982; 115: 736-51
14. Glezen WP, Couch RB. Interpandemic infection in the Houston area, 1974-1976. N Engl J Meal 1978; 298: 587-92
15. Fox JP, Hall CE, Cooney MK, et al. Influenza virus infections in Seattle families, 1975-1979: I. study design, methods and the occurrence of infections by time and age. Am J Epidemiol 1982; 116: 212-27
16. Health care financing administration common procedure coding system (HCPCS). Salt Lake City (UT): Medicode, 1999
17. Current procedural terminology (CPT). Chicago (IL): American Medical Association, 1999
18. SAS Institute Inc. SAS/STAT User's Guide, release 6.12th ed. Cary (NC): SAS Institute Inc, 1997
19. Treanor JJ, Hall CB. Influenza and infections of the trachea, bronchi, and bronchioles. In: Reese RE, Betts RF, editors. A practical approach to infectious diseases. 4th ed. New York: Little Brown, 1996: 240-57
20. Connoly AM, Salmon RL, Lervy B, et al. What are the complications of influenza and can they be prevented?: experience from the 1989 epidemic of H3N2 influenza A in general practice. BMJ 1993; 306: 1452-4
21. Neuzil KM, Reed GW, Mitchel EF, et al. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281: 901-7
22. Glezen WP, Greenberg SB, Atmar RL, et al. Impact of respiratory virus infection on persons with chronic underlying conditions. JAMA 2000; 283: 499-505
23. Meier CR, Napalkov PN, Wegmuller Y, et al. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19: 834-42
24. Mullooly JP, Barker WH. Impact of type A influenza on children: a retrospective study. Am J Public Health 1982; 72: 1008-16
25. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health 2000; 3: 32-8
26. McEvoy GK, editor. American hospital formulary service. Bethesda (MD): American Society of Health-System Pharmacists, 2000
27. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Meal 2000; 342: 225-31
28. Knottnerus JA. Influenza in the Netherlands. Pharmacoeconomics 1996; 9 Suppl. 3: 46-9
29. Centers for Disease Control. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2002; 51 (RR-3): 1-34